Introduction to Cathelicidin LL-37

The host-defense peptide cathelicidin LL-37 serves as a critical component of the human innate immune system. It exhibits broad-spectrum antimicrobial effects against bacteria, viruses, and fungi. Furthermore, recent research has highlighted that the cathelicidin LL-37 antimicrobial activity is deeply rooted in its ability to aggregate and form fibrils. Understanding these molecular interaction modes is essential for developing novel antibacterial agents to combat rising resistance.

Molecular Mechanisms of Aggregation

Research using discrete molecular dynamics (DMD) simulations reveals that the active core of the peptide, LL37(17-29), relies on specific structural dynamics. The wild-type (WT) peptide forms stable helix-helix contacts driven primarily by hydrophobic interactions. These helices eventually aggregate into densely packed fibrils. Consequently, this fibrillization process correlates directly with potent antimicrobial performance. However, even minor mutations can drastically alter these properties.

Impact of F17S and I24K Mutations

Structural flexibility plays a major role in peptide effectiveness. The F17S mutation, for instance, results in a more flexible peptide structure. Although it maintains a similar monomeric form to the WT, it develops only weak interpeptide contacts. This lack of stability inhibits proper aggregation and weakens its antimicrobial effect. In contrast, the I24K mutation totally abolishes activity. While the I24K monomer shows a promoted helical structure, enhanced electrostatic repulsions and reduced hydrophobic interactions prevent aggregation entirely.

Insights into Cathelicidin LL-37 Antimicrobial Activity

For clinicians and researchers, these findings offer a blueprint for rational drug design. By manipulating hydrophobic and electrostatic balances, scientists can potentially engineer synthetic analogs with improved stability and lower toxicity. Moreover, studies conducted in India, such as those at the ICMR-National Institute of Virology, have explored LL-37's potential against viruses like Dengue, emphasizing its clinical relevance in the region. Therefore, maintaining the peptide\'s ability to form fibrils remains a key goal for future therapeutic applications.

Frequently Asked Questions

What is the primary role of LL-37 in the body?

LL-37 is a human host-defense peptide that provides innate immunity. It kills pathogens directly through membrane disruption and modulates the immune response by attracting other immune cells to infection sites.

How do mutations like I24K affect LL-37 function?

The I24K mutation increases electrostatic repulsion and reduces the hydrophobic drive needed for peptides to stick together. This prevents the formation of antimicrobial fibrils, rendering the peptide inactive against microbes.

Why is peptide aggregation important for antimicrobial activity?

Aggregation allows the peptides to form stable, densely packed structures that can more effectively disrupt bacterial membranes. Without this aggregation, the individual peptides lack the structural integrity to maintain sustained antimicrobial pressure.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.

References

Jin X et al. Molecular interaction modes of the host-defense peptide cathelicidin LL-37 and its mutants dictate diverse antimicrobial activities. Nanoscale. 2026 Apr 07. doi: 10.1039/d5nr03981a. PMID: 41945358.

Alagarasu K et al. In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2. Peptides. 2017 Jun;92:23-30. doi: 10.1016/j.peptides.2017.04.002. PMID: 28400226.

Qi X et al. Unveiling the inhibition mechanism of host-defense peptide cathelicidin LL-37 on the amyloid aggregation of the human islet amyloid polypeptide. Nanoscale. 2025. doi: 10.1039/D4NR03321F.